On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Glaxosmithkline Biologicals SA's own share of each project, not the project's full budget.
- Horizon 2020€14.1M · 13 projects
- FP7 (2007 to 2013)€1.0M · 12 projects
- Horizon Europe€0 · 1 project
- Erasmus+ (ERASMUS+)€0 · 1 project
Projects
27 EU-funded projects, newest first. Glaxosmithkline Biologicals SA led 4 of them as coordinator. Each links to the official record.
- Project-COMFORTAssociated partner
Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)
Horizon Europe · 2024–2028 · Project on CORDIS ↗
- LIVE_InnovAssociated partner
Leading International Vaccinology Education for Innovation
Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗
- PROMISEPartner
Preparing for RSV Immunisation and Surveillance in Europe
Horizon 2020 · 2021–2024 · Project on CORDIS ↗
- PrIMAVeRaPartner
Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance
Horizon 2020 · 2021–2026 · Project on CORDIS ↗
- Inno4VacPartner
Innovations to accelerate vaccine development and manufacture
Horizon 2020 · 2021–2028 · Project on CORDIS ↗
- Vacc-iNTSAssociated partner
Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa
Horizon 2020 · 2019–2026 · Project on CORDIS ↗
- VITALPartner
Vaccines and Infectious Diseases in the Ageing PopuLation
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
- COMBACTE-CDIPartner
Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections
Horizon 2020 · 2017–2021 · Project on CORDIS ↗
- DRIVEPartner
Development of Robust and Innovative Vaccine Effectiveness
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
- RESCEUPartner
REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
- PERISCOPEPartner
PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910
Horizon 2020 · 2016–2022 · Project on CORDIS ↗
- VAC2VACPartner
Vaccine lot to Vaccine lot comparison by consistency testing.
Horizon 2020 · 2016–2022 · Project on CORDIS ↗
- FLUCOPPartner
Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection
FP7 (2007 to 2013) · 2015–2020 · Project on CORDIS ↗
- DiViNeAssociated partner
Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes
Horizon 2020 · 2015–2020 · Project on CORDIS ↗
- TBVAC2020Partner
TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
- EbolaVacCoordinator
Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine
Horizon 2020 · 2014–2018 · Project on CORDIS ↗
€14.1Mtheir share - EXALTPartner
Proposal to assess an innovative Immunotherapy, based on a thioredox peptide antigen, in a Phase I Trial for Type-1 Diabetes
FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗
€285ktheir share - DAVIADPartner
The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€15ktheir share - ADVANCEPartner
Accelerated Development of Vaccine benefit-risk Collaboration in Europe
FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗
- ADJSYNCoordinator
Understanding how immunostimulant combinations in adjuvants synergise to enhance vaccine responses
FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗
€170ktheir share - T-BACCoordinator
Exploring the roles and plasticity of T-cell responses in anti-BACterial immunity
FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗
€170ktheir share - PEACHIPartner
Prevention of hepatitis C virus (HCV) and HIV-1 co-infections through induction of potent T cell responses using prime-boost viral vector vaccine regimens
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
- €25ktheir share
- BIOVACSAFEPartner
Biomarkers For Enhanced Vaccine Safety
FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
- SIMULATACoordinator
System for Immunological Modelling as an Ultimate tool to Link Adjuvant function To Adaptive immune responses
FP7 (2007 to 2013) · 2010–2012 · Project on CORDIS ↗
€221ktheir share - NEWTBVACPartner
Discovery and preclinical development of new generation tuberculosis vaccines
FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗
€150ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 15 shared projects
- Sanofi R&d VaccinsFrance · 12 shared projects
- Imperial College of Science Technology and MedicineUnited Kingdom · 8 shared projects
- Statens Serum InstitutDenmark · 8 shared projects
- Department of HealthUnited Kingdom · 8 shared projects
- Pfizer LimitedUnited Kingdom · 8 shared projects
- Rijksinstituut Voor Volksgezondheid en Milieu (Rivm)Netherlands · 7 shared projects
- Istituto Superiore di SanitaItaly · 7 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 6 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 6 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 5 shared projects
- Universitair Medisch Centrum UtrechtNetherlands · 5 shared projects
- Institut PasteurFrance · 5 shared projects
- University of SurreyUnited Kingdom · 5 shared projects
- Universita Degli Studi di SienaItaly · 5 shared projects
- Astrazeneca ABSweden · 5 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- HIV
- alkali metals
- antibiotic resistance
- antibiotics
- asthma
- autoimmune diseases
- bacteriology
- big data
- biomolecules
- carbohydrates
- data mining
- databases
- diabetes
- differential equations
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
